Bayesian Capital Management’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,418
Closed -$193K 846
2022
Q4
$193K Buy
+10,418
New +$178K 0.03% 607
2021
Q3
Sell
-3,200
Closed -$341K 411
2021
Q2
$341K Sell
3,200
-1,919
-37% -$189K 0.09% 243
2021
Q1
$459K Buy
5,119
+302
+6% +$33.2K 0.11% 247
2020
Q4
$484K Sell
4,817
-2,383
-33% -$178K 0.13% 220
2020
Q3
$352K Buy
+7,200
New +$346K 0.09% 308

Other funds holding CRNC

Bayesian Capital Management's CRNC Position: Q1 2023 in Review

Bayesian Capital Management sold out of Cerence (CRNC) in Q1 2023, closing a stake of 10,418 shares — an estimated $193K sold.

Bayesian Capital Management first reported a position in CRNC in Q3 2020 and held it in 5 quarters. The position peaked at $484K in Q4 2020. 228 funds tracked by Wall St. Rank hold CRNC as of Q1 2023.

  • Bayesian Capital Management reported no remaining Cerence position as of Q1 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 10,418 Cerence shares in Q1 2023, an estimated $193K.
  • Bayesian Capital Management first reported a position in Cerence in Q3 2020 and held it in 5 quarters.
  • Bayesian Capital Management's Cerence position peaked at $484K in Q4 2020.
  • 228 funds tracked by Wall St. Rank held Cerence as of Q1 2023.

Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.